Deciphering Developmental Disorders
UK drug repurposing study identifies several potential dementia treatments
An estimated 982,000 people in the UK are currently living with the neurodegenerative disease
Common antidiabetic drug metformin found to slow growth of precancerous cells
The findings suggest that the drug could be used to manage squamous oesophageal cancer risk
New genomic technique could improve antibiotic-resistant bacteria tracking in hospitals
The sequencing method is able to track the spread of multiple bacteria at the same time
AI tool better predicts progress of Alzheimer’s versus current clinical tests
The most common form of dementia accounts for up to 80% of all cases
Study identifies thousands of high-risk cancer gene variants and potential therapeutic target
Patients with inherited variants of the BAP1 gene have a 50% increased risk of developing certain cancers
New study aims to identify IBD biomarkers for personalised medicine
The chronic gastrointestinal condition affects more than 540,000 people in the UK
Study finds siblings with unique genetic defects could help progress type 1 diabetes drug search
The chronic, life-long disease affected around 8.4 million people worldwide in 2021
Researchers’ new vaccine technology shows efficacy against broad range of coronaviruses
The vaccine provided protection against coronaviruses that have not yet emerged
New immune cell discovery could lead to personalised breast cancer treatments
The study revealed the key features of immune cells in helping the body’s immune system fight cancer
UK study reveals significantly higher risk of second cancers among breast cancer survivors
Breast cancer is currently the most commonly diagnosed cancer in the UK, affecting around 56,000 people annually
Single genetic test could replace current standard for diagnosing rare developmental disorders
The single genetic test could potentially replace the current standard and reduce costs for the NHS
Study reveals molecular signatures driving immune cell attacks in chronic neurological diseases
MS is a chronic neurological disease that affects more than two million people worldwide